NEWS
3D bioprinting technique could create artificial blood vessels, organ tissue
University of Colorado Boulder engineers have developed a 3D printing technique that allows for localized control of an object's firmness,...
Olaparib maintenance extends PFS by estimated 3 years in advanced ovarian cancer
Credit: © European Society for Medical Oncology Munich, Germany, 21 October 2018 - Two-year maintenance therapy with olaparib, a PARP...
Home-based biofeedback therapy is effective option for tough-to-treat constipation
Credit: Phil Jones, Senior Photographer, Augusta University AUGUSTA, Ga. (Oct. 22, 2018) - Biofeedback therapy used at home is about...
HIV-infected Hispanic adults face higher risks of HPV-related cancers
A new study reveals that Hispanic HIV-infected adults in the United States are at a higher risk of developing cancers...
Heredity matters: Ancestral protease functions as protein import motor in chloroplasts
Credit: Osaka University Osaka, Japan -- Over 1 billion years ago, a relationship began between the ancestor of all living...
New treatment approach for advanced anal cancer
ESMO 2018 abstract LBA21 - "InterAACT: A multicentre open label randomised phase II advanced anal cancer trial of cisplatin (CDDP)...
Future fertility: Giving hope to men who received childhood cancer treatment
Credit: Dong-Ha Bhang, Penn Medicine: Nature Communications PHILADELPHIA - Researchers have discovered a way to grow human stem cells destined...
Oncologists demand more education on the use of biosimilars: ESMO takes action
Biological medicines are responsible for some of the most promising innovations in cancer treatment, including immunotherapy, targeted drugs and vaccines...
Multi-strain probiotic reduces chemotherapy-induced diarrhoea [ESMO 2018 Press Release]
Credit: © European Society for Medical Oncology Munich, Germany, 21 October 2018 - A high concentration of multi-strain probiotic helps...
Zoledronic acid improves disease-free survival in premenopausal HR+ early breast cancer
Munich, Germany, 20 October 2018 - Adjuvant treatment with the bone sparing drug zoledronic acid plus hormonal therapy with the...
Epigenetic therapy worth pursuing in hormone receptor positive advanced breast cancer
Credit: © European Society for Medical Oncology Munich, Germany, 20 October 2018 - Epigenetic therapy with histone deacetylase (HDAC) inhibitors...
Targeting specific genomic mutation in breast cancer improves outcomes, first study shows
(European Society for Medical Oncology) Targeting a common mutation in patients with hormone receptor positive (HR+) HER2 negative (HER2-) advanced...
Bright lights, big CITI
Credit: Duke-NUS Medical School Singapore, 22 October 2018 - Global efforts in immuno-oncology have received a major boost, with a...
Immunotherapy may become new first line treatment in some metastatic colorectal cancers
Credit: © European Society for Medical Oncology Munich, Germany, 22 October 2018 - Immunotherapy with nivolumab and low-dose ipilimumab could...
POPULAR NEWS
-
James Webb Space Telescope captures the end of planet formation
-
Aston University to help Saudi Arabia turn waste into energy
-
Mediterranean marine worm has developed eyes “as big as millstones”
-
Professor Miguel Ángel García receives the prestigious ERC Advanced Grant from the European Research Council